Induction Of Remission

ORLANDO — Duration of remission prior to post-transplant relapse, as well as survival after relapse, appeared to be strong independent predictors of whether pediatric patients with high-risk leukemia or myelodysplastic syndrome can receive a second allogeneic hematopoietic stem cell transplant, according to results of a retrospective study presented at TCT | Transplantation & Cellular Therapy Meetings.